Suppr超能文献

心房颤动透析患者心率控制与抗心律失常药物使用与缺血性卒中和死亡风险的关联

Association of Rate-Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation.

作者信息

Lidgard Benjamin, Fan Dongjie X, Zelnick Leila R, An Jaejin, Harrison Teresa N, Lee Ming-Sum, Singer Daniel, Tabada Grace H, Go Alan S, Bansal Nisha

机构信息

Division of Nephrology University of Washington Seattle WA USA.

Division of Research Kaiser Permanente Northern California Oakland CA USA.

出版信息

J Am Heart Assoc. 2025 Jun 17;14(12):e038511. doi: 10.1161/JAHA.124.038511. Epub 2025 Jun 16.

Abstract

BACKGROUND

Incident atrial fibrillation (AF) is common among adults with kidney failure treated with maintenance dialysis and is associated with poor clinical outcomes. Limited data exist informing treatment of AF among patients on dialysis. We aimed to describe the use of rate-control and antiarrhythmic medications for AF among patients on dialysis and associations of these medication use strategies with stroke and all-cause death.

METHODS

We evaluated patients on dialysis with incident AF between 2010 and 2017 in the Kaiser Permanente Northern and Southern California integrated health care delivery systems. We characterized time-updated receipt of rate-control (β blockers, calcium channel blockers, and digoxin) and antiarrhythmic medications from pharmacy databases. We evaluated associations of these therapies with the composite outcome of ischemic stroke and all-cause death using Cox regression, adjusting for potential confounders.

RESULTS

Of 2100 patients, 44.0% were newly prescribed rate-control medications, 4.6% were prescribed antiarrhythmic medications, 8.9% were prescribed both, and 42.9% were prescribed neither within 12 months of newly diagnosed AF. During a median 1.66 (interquartile range, 0.45-3.39) years, we observed 1406 composite events (stroke and death). Time-updated use of antiarrhythmics alone (adjusted hazard ratio [HR], 0.74 [95% CI, 0.57-0.96]) or with rate-control (adjusted HR, 0.72 [95% CI, 0.58-0.90]) was associated with lower stroke or death risk versus neither medication. Use of rate-control medications alone was not significantly associated with the composite outcome.

CONCLUSIONS

Among patients on dialysis with incident AF, use of antiarrhythmic medications may be associated with lower risk of stroke and death. Future randomized trials are needed to determine the efficacy and safety of antiarrhythmic medications in this high-risk population.

摘要

背景

新发房颤在接受维持性透析治疗的成年肾衰竭患者中很常见,且与不良临床结局相关。关于透析患者房颤治疗的数据有限。我们旨在描述透析患者中房颤的心率控制和抗心律失常药物的使用情况,以及这些药物使用策略与中风和全因死亡的关联。

方法

我们评估了2010年至2017年在凯撒永久医疗集团北加利福尼亚和南加利福尼亚综合医疗服务系统中接受透析且新发房颤的患者。我们从药房数据库中确定了心率控制药物(β受体阻滞剂、钙通道阻滞剂和地高辛)和抗心律失常药物的时间更新使用情况。我们使用Cox回归评估了这些治疗与缺血性中风和全因死亡复合结局的关联,并对潜在混杂因素进行了调整。

结果

在2100名患者中,44.0%在新诊断房颤后的12个月内新开具了心率控制药物,4.6%开具了抗心律失常药物,8.9%两者都开具了,42.9%两者都未开具。在中位1.66年(四分位间距,0.45 - 3.39年)期间,我们观察到1406例复合事件(中风和死亡)。与两种药物都未使用相比,单独使用抗心律失常药物(调整后风险比[HR],0.74[95%置信区间,0.57 - 0.96])或与心率控制药物联合使用(调整后HR,0.72[95%置信区间,0.58 - 0.90])与较低的中风或死亡风险相关。单独使用心率控制药物与复合结局无显著关联。

结论

在接受透析且新发房颤的患者中,使用抗心律失常药物可能与较低的中风和死亡风险相关。未来需要进行随机试验来确定抗心律失常药物在这一高危人群中的疗效和安全性。

相似文献

8
Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.心脏手术患者的同期心房颤动手术。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD011814. doi: 10.1002/14651858.CD011814.pub2.

本文引用的文献

2
Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD.成人新发房颤伴或不伴 CKD 的管理。
J Am Soc Nephrol. 2022 Feb;33(2):442-453. doi: 10.1681/ASN.2021060744. Epub 2021 Dec 17.
3
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
4
Why Test for Proportional Hazards?为什么要检验比例风险?
JAMA. 2020 Apr 14;323(14):1401-1402. doi: 10.1001/jama.2020.1267.
7
Hyperkalemia: pathophysiology, risk factors and consequences.高钾血症:病理生理学、危险因素和后果。
Nephrol Dial Transplant. 2019 Dec 1;34(Suppl 3):iii2-iii11. doi: 10.1093/ndt/gfz206.
8
Flecainide toxicity in renal failure.肾衰竭中的氟卡尼毒性
Proc (Bayl Univ Med Cent). 2018 May 9;31(3):328-330. doi: 10.1080/08998280.2018.1463042. eCollection 2018 Jul.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验